We recently published a list of Top 10 Stocks on Jim Cramer’s Radar as Trump Tariffs Wreak Havoc Across Global Markets. In ...

Georgia lawmakers are hoping to pass a bill before the legislative session ends Friday that would allow pharmacists to distribute HIV prevention medicines without a prescription, a policy change that ...

FDA 授予 PEP-010 孤儿药资格，该药物是一种首创的双功能治疗肽，可用于治疗转移性胰腺癌患者。PEP-010 是 PEP-Therapy 的首创双功能治疗肽，目前正在进行 Ib 期临床试验，以评估其与化疗（紫杉醇或吉西他滨）联合使用时的安全性 ...

French biotech Pep-Therapy SAS is in the midst of raising a €20 million (US$21.62 million) round and, at the same time, prospecting for potential partners after winning FDA orphan drug designation for ...

In times of economic downturns, with much uncertainty surrounding the U.S. economy and Trump’s infamous import tariffs, a ...

Things have not been great for beverage giant PepsiCo (PEP) of late. With weight-loss drugs cutting into snack purchases and ...

Post-exposure prophylaxis (PEP) is a method of preventing HIV infection. It involves using a four-week course of the drugs used to treat HIV, taken very soon after a person may have been exposed to ...

In this article, we are going to take a look at where PepsiCo Inc (NASDAQ:PEP) stands against other top stocks on Jim Cramer’s radar as Trump tariffs wreak havoc across global markets.

PEP-010 has received orphan drug designation for pancreatic cancer, emphasizing the need for novel treatments in this high-mortality disease. The peptide disrupts Caspase-9 and PP2A interaction, ...

Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology, announced that the U.S. Food and Drug ...

PepsiCo (PEP) price history over the past twelve months ... more health-conscious options and turn to GLP-1 weight-loss drugs. These drugs already have around 15 million regular users in the ...